Sean Lammen
Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
About Sean Lammen
Sean Lammen is recorded as Analyst at Morgan Stanley. Sean Lammen has spoken on 1 earnings call across 1 company, most recently for Biomarin Pharmaceutical Inc on November 2, 2026. The companies whose calls Sean Lammen spoke on are classified in the Healthcare sector.
Sean Lammen on recent calls
“On POMO, the patient growth was around 69%, but you've acknowledged that uptake benefited from the competitor supply constraints. Alexander, can you quantify the underlying growth, excluding that disruption?”
Affiliation history
-
Morgan Stanley
Analyst
Transcript header (unverified)
Current